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Abstract
Neurodegeneration, a progressive loss of nerve cells, occurs in many neurological
disorders, including Alzheimer’s disease (AD) and Parkinson’s diseases (PD), as well as in
dementia. The pathogenesis of these diseases is unknown, and recent evidence suggests that
environmental factors, which act as endocrine-disrupting compounds (EDCs) could play a
significant role in developing the disease process. 4-Nonylphenol (4-NP), an EDC, and a
ubiquitous environmental toxin has been shown to affect brain development and may cause
neurodegeneration. 4-NP is produced in large quantities in the U.S. and used as raw materials for
making detergents, pesticides, plastics, paints, cosmetics, rubber, and other industrial/household
products that lead to its widespread release to the environment. However, the underlying
molecular mechanism of 4-NP-induced neurodegeneration is not understood. Recent results from
our laboratory indicate that 4-NP inhibits nerve growth factor (NGF)-induced neuronal
differentiation of PC12 cells, causes cellular aggregation and interferes with microtubule (an
important component of the neuronal cytoskeleton) organization. The expression of tau, a
microtubule-associated protein (MAP) known to play a key role in neurodegeneration was
increased significantly in the presence of 4-NP.

High-Resolution proteomic analysis of a

cytoskeletal fraction (CSKF) reveals that 4-NP altered the proteomic landscape of CSK and
increased the association of several proteins, including proteins of Alzheimer’s (AD) and
Parkinson’s disease (PD) pathways, with the cytoskeleton (CSK). 4-NP has been shown to
inhibit tubulin-G interactions. G is an important component of the GPCR (G proteincoupled receptor) signaling pathway and its interaction with tubulin/MTs has been shown to be
important for MT assembly and neurite outgrowth. Based on these results I hypothesize that 4NP induces neurodegeneration by disrupting cytoskeleton and altering expression/localization of
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Tau protein. We further hypothesize that G and downstream PI3K/pAkt/pGSK3 signaling
pathway is involved in this process. Because PC12 cells are not of neuronal origin, in the current
study I also used human neuronal cells SHSY5Y. In Specific Aim 1, using biochemical, and
immunoconfocal methodologies, I have demonstrated that 4-NP inhibited neurite formation and
disrupted MT assembly and organization in both SHSY5Y and PC12 cells. Tau and tubulin
localization was dramatically altered in the presence of 4-NP and no colocalization was observed
as seen in control cells. In Specific Aim-2, I have conducted co-immunoprecipitation analysis
and demonstrated the 4-NP significantly inhibited tubulin-G interactions in SHSY5Y cells. In
addition, the PI3K pathway was also affected by 4-NP as shown by inhibition of phosphorylation
of Akt and GSK3b in the presence of 4-NP.
Our study clearly demonstrates the potential risk of 4-NP in disrupting cytoskeleton and
inducing neurodegeneration and should provide essential information in accessing the
environment risk of 4-NP.
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Chapter 1: Introduction
1.1 4-Nonylphenol.
Endocrine-disrupting compounds (EDCs) have been the focus of research in recent years
because of the growing concerns of the health risks they pose. They are widespread in our
environments. It has been shown that EDCs may disturb homeostatic control and cause
psychological disorders. It has toxic effects on the reproductive, digestive, and immune systems
(Jie, 2013; Matsunaga, 2010). The potential effects of EDCs on the central nervous system
(CNS) have prompted concern in recent years (Jie, et al., 2013).
4-Nolylphenol (4-NP), one of the most prevalent EDC, is a synthetic organic chemical
produced in relatively large quantities in the U.S. to synthesize Nonylphenol polyethoxylate
(NPE). NP is a compound that has numerous isomers. The side chain has nine carbons and can
be attached to phenol at different points on the ring, thus producing different isomers. 4-NP is the
most common commercial form of NP (Mao, et al., 2012) and has been reported to have
deleterious effects on CNS altering cognitive function and neurotoxicity of tissues (Jie et al.,
2013). 4-NP is usually used to produce nonylphenol polyethoxylates (NPEs). NPEs are mainly
used in a number of industrial processes and products, including cleaners, pesticides, paint,
detergents, and plastics. (Mao, et al., 2012) (Fig.1). 4-NP is widely released in the environment
as a degradation product of NPE (US Environmental Agency, 2010; IRA Office of
Environmental Health Hazard Assesment, 2009). It has been detected in surface and
groundwater, sediment, wastewater effluent, and air (Knepper, 2003; Gautam et al, 2015;
Toxnet). It is highly toxic to aquatic organisms. Human exposure to 4-NP may occur through
contact with detergents and products containing this chemical compound, as well as through the
ingestion of contaminated water or food. The molecule has been detected in human breast milk,
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blood, and urine, raising a concern of toxic effects of 4-NP in human health (Sise, 2017; Li X, et
al., 2013). NP easily accumulates in animal and human tissues due to its hydrophobicity (Zhang,
et al., 2016). Because of its lipophilic nature, 4-NP can cross the blood-brain barrier (BBB),
exerting its diverse effects on the central nervous system (CNS) (Zhang et al., 2008). More
recently, oral administration of low doses of 4-NP in adult rats resulted in learning and memory
impairment, which correlated with its concentration in specific brain regions (Kazemi, 2018),
and further supports the ability of the molecule to concentrate in the brain tissue and affect the
functional dysfunction of the nervous system. Due to the potential toxicity issues of NP, the
“Oslo and Paris Commission for the Protection of the Marine Environment of the north-east
Atlantic” called for phasing out the use of NPEs in domestic cleaning agents by 1995 and in
industrial cleaning agents by 2000 (Ferra, et al. 2001). Following these recommendations,
European countries have restricted or banned the use of NPEs. In the United States, the use of
NPs is still permitted, with certain limitations. In 2006, the U.S. Environmental Protection
Agency (EPA) released final aquatic life ambient water quality criteria for NP, which
recommends NP concentrations in both freshwater (28 μg/L, acute; 6.6 μg/L, chronic) and
saltwater (7.0 μg/L, acute; 1.7 μg/L chronic). However, a debate concerning the level of risk of
4-NP is still ongoing by researchers, regulators, and manufacturers.

2

Figure 1. Chemical Structures of nonylphenol polyethoxylate and nonylphenol
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1.2 Neurodegeneration and 4-NP.
Neurodegeneration refers to a pathological condition associated with the progressive
atrophy, loss of function, and ultimately death of nerve cells in the brain and peripheral nervous
system, and occurs in diseases or disorders such as Alzheimer’s disease (AD), Parkinson’s
disease (PD), Huntington disease (HD), dementia, and others. Cytoskeletal disruption and
aggregation of proteins in neurons is the hallmark of neurodegeneration. (Alonzo, 2008; Amniai,
2008; Gustav-rothenbergg, 2010). The most consistent risk factor for developing a
neurodegenerative disorder is aging (Tanner. 1992) and recent evidence suggest a role of genetic
and environmental factors in the initiation of these diseases. However, the causes of
neurodegenerative diseases are essentially unknown, and the mechanisms by which they initiate
the disease remain, at best, speculative. (Przedborski, et al., 2003).
4-NP has been shown to induce behavioral as well as learning and memory capacity
alterations in the male offspring of Sprague Dawley rats. (Xu, et al., 2010). Alongside, 4-NP
treatments administrated to mothers during gestation, resulted in deterioration of neuronal
development, decrease in memory and learning capacity and spatial learning in monkey and rat
offsprings. (Yoshikawa, 2005) These data suggest that 4-NP might have a potentially damaging
effect during early neurodevelopment. Other studies indicate that 4-NP treatment causes the
death of neuronal stem cells suggesting that 4-NP could directly cause neurodegeneration (Kudo
et al., 2004). 4-NP also was able to inhibit the MAP2-mediated neurite outgrowth. (Matsunaga et
al, 2010).
More recently, 4-NP has been shown to inhibit neurotrophin-dependent neurite outgrowth
in cultured embryonic Xenopus spinal-cord neurons and PC12 cells (a cell line derived from a
pheochromocytoma of the rat adrenal medulla that can show neurite like morphologies after
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NGF treatment). Surprisingly, the effect of 4-NP was not inhibited by nuclear estrogen receptor
antagonist, ICI182-780, but was inhibited by the G-protein antagonist, pertussis toxin (Bevan, et
al, 2006) suggesting a role of G-protein signaling in this process.
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1.3 Neuronal cytoskeleton and neurodegeneration.
The cytoskeleton provides structural organization for the cell interior, serve as tracks for
intracellular transport, and comprises the core framework of cellular morphologies. The shape of
the cells in the nervous system is closely connected to their functions. (Kirkpatrick and Brady,
1999). In neurons, the ability to achieve proper connections between the correct set of cells
depends on the polarized organization into axons and dendrites. Microtubules (MTs) and actin
filaments are core components of the cytoskeleton and are assembled through head-to-tail
polymerization of α- and β-tubulin heterodimers and actin monomers, respectively, resulting in
asymmetric, polarized polymers with two different ends. (Tas, et al., 2018). Both MTs and actin
filaments are dynamic structures with the ability to continuously grow and shrink, which
facilitates the continuous remodeling of the cytoskeleton. (Kevenaar and Hoogenraad, 2015).
Microtubules (MTs) form dense, parallel arrays in axons and dendrites that are required for the
growth and maintenance of these neurites (Witte and Bradke; Geraldo and Gordon-Weeks,
2009). In contrast, actin filaments are enriched in the growth cone and organized into long
bundles forming filamentous protrusions (filopodia) or veil-like sheets of branched actin
(lamellipodia) (Witte, 2008; Geraldo, 2009) (Fig.2). The dynamics of MTs are regulated by a
large number of factors, including microtubule-associated proteins (MAPs). (Dehmelt and
Halpain, 2005).
During neurodegeneration, the proper association and arrangement of cytoskeleton
components are severely compromised. When neurodegeneration occurs several hallmark
conditions are observed, such as altered protein folding, amyloid plaques, neurofibrillary tangles,
Lewy bodies, impaired cellular transport, increased oxidative stress among many others
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(Jellinger, 2010). However, as mentioned before, the mechanism by which diseases are triggered
and then progress is poorly understood.

Fig. 2 Neuronal Cytoskeleton. Representation of the cytoskeletal organization in
neuronal cells. Microtubules form dense arrays mainly along the axon and dendrites of the cell
(shown in red). The actin filaments, represented in green, localized primarily on the tips of the
processes, forming lamellipodium and filopodium. Lastly, shown in blue are the microtubuleassociated proteins, which help in the dynamic stability of the cell.
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1.4 Microtubule associated proteins, Tau and Neurodegeneration.
Microtubule dynamics in neurons is modulated by several accessory proteins termed
microtubule-associated proteins (MAPs). Tau is an important microtubule-associated protein
found in axons and is known to regulate MT assembly and neurite outgrowth. Tau functions in
the stabilization and regulation of microtubule assembly are regulated by its phosphorylation
state. (Herbert, 2013). Tau protein is a family of six isoforms, each with either three or four MTbinding repeats located in the C-terminal half of the protein and zero to two inserts located in the
N-terminal portion. (Goedert and Jakes, 1990). Tau isoforms are developmentally regulated and
have similar levels in the adult human brain. (Kosik, 1989). When detached from microtubules,
Tau can self-aggregate through its hexapeptide motifs in the repeat domain. (Bergen, et al.,
2000). In several neurodegenerative diseases, tau is hyperphosphorylated and aggregated to
neurofibrillary tangles (NFT) which is likely to play a role in the pathogenesis of diseases.
(Johnson, and Stoothoff, 2004).

Figure 3. Tau in healthy neuronal cells and formation of NFTs in diseased cells. In normal
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neurons, tau participates in MT stabilization, helping to preserve neuronal integrity and facilitating
neuronal function. During neurodegeneration, tau becomes hyperphosphorylated and does not bind to
MTs, forming abnormal aggregates that are deposited in the cells. This leads to impaired MT stability,
axonal damage, and overall loss of neuronal integrity. Reprinted by permission from Macmillan
Publishers Ltd: Nature Reviews Drug Discovery (Brunden et al., 2009).
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1.5 G-protein signaling pathway, Microtubule assembly and Neurite outgrowth.
Microtubule assembly, as mentioned above, is a dynamic process that must be tightly
regulated in order to accomplish the proper morphology and therefore connectivity between
neuronal cells. There are different pathways that can regulate microtubule assembly and
disassembly in neurons. Previous studies from our laboratory have indicated that MT assembly
could be regulated by G protein-mediated signaling (Roychowdhury and Rasenick, 1997;
Roychowdhury et al., 1999; Roychowdhury et al., 2006; Montoya et al., 2007). G-proteinmediated signaling, a major signaling pathway, consists of three major components: G-protein
coupled receptors (GPCRs), G protein, and effector molecules. GPCRs are transmembrane
proteins and mediate different extracellular signals, like light, odorants, peptide hormones, and
neurotransmitters. G proteins serve as signal transducers and are composed of three subunits:
GGand GWhen an agonist binds to GPCR, the G protein goes into an active state,
disassociating the Gsubunit from the Gallowingboth to participate in intracellular signaling
process (Gilman, 1987; Dohlman et al., 1991; Neves et al., 2002; McCudden et al., 2005). It is
the Gcomplex that has been shown to promote microtubule assembly and induce neuronal
differentiation. (Fig. 4) (Roychowdhury and Rasenick, 1997; Montoya et al., 2007; SierraFonseca et. al 2014). It was noticed that reconstituted heterotrimers would not show signs of
coupling with MTs nor taking part in modulating MT Assembly, coming to the conclusion that G
protein activation was necessary for Gdependent MT assembly (Roychowdhury et.al 2006)
(Fig. 4). Using the anti-mitotic agent nocodazole, it has been demonstrated that the tubulin-Gβγ
interaction is important for MT assembly in cultured PC12 and NIH3T3 cells (Montoya et al.,
2007). More recently, it was found that Gβγ–MT interaction is critical for NGF-induced neuronal
differentiation of PC12 cells (Sierra-Fonseca et. al 2014). Overexpression of Gβγ in PC12 cells
(in the absence of NGF) induced neurite formation similar to that seen in NGF-differentiated
cells. Altogether, results from our laboratory suggested that the Gβγ, initiated by the activation of
the G protein-coupled receptor (GPCR), is a signal-transducing protein complex, and its
10

interaction with microtubules (MTs) is important to neuronal development, differentiation,
structure, and neurodegeneration (Fig. 4).

Fig 4. Gβγ signaling, MT assembly and Neurite outgrowth. Activation of GPCR
triggers the disassociation of the G heterotrimer into G and G subunits. These subunits
play a role in the activation of several signaling pathways such as adenylyl cyclase,
phospholipases, and PI3-Kinases. It has been previously found from our laboratory that G
subunit interacts with  tubulin heterodimers to stimulate microtubule assembly and to induce
neurite outgrowth in pheochromocytoma (PC12) cells (Roychowdhury and Rasenick, 1997;
Montoya et al., 2007; Sierra-Fonseca et. al 2014)

1.5.1 Receptor Tyrosine kinase-A (TrkA), PI3K, MT assembly and Neurite outgrowth.
A different signaling pathway that can influence microtubule assembly, involves the
phosphatidyl inositol-3-kinase (PI3K) enzyme. Being part of the downstream signaling for the
receptor Tyrosine kinase-A (TrkA) pathway, PI3K appears to take part in regulating the
assembly of MTs/actin filaments via further downstream signaling (Cantley, 2002; Zhou et al.,
2004). Two downstream effectors of PI3K that have been shown to participate in the regulation
of neurite outgrowth and are particularly associated with cytoskeletal remodeling, are Akt (a
11

serine/threonine-specific protein kinase) and the glycogen synthase kinase 3 (GSK3). The
regulation is neurite outgrowth by PI3K is dependent on the ability of the PI3-kinases to
phosphorylate and activate the AKT that is followed by the inhibition of the GSK-3by the
phosphorylation of this enzyme (Fig.5). The role of PI3K in neuronal differentiation has been
demonstrated using PC12 cells (endocrine chromaffin cells), a model cell line to study neuronal
differentiation. PC12 cells respond to nerve growth factor (NGF) with growth arrest and exhibit
a typical neuronal phenotype of neurite extensions. NGF has been shown to activate
PI3K/Akt/GSK3 (Trk-A receptor pathway) to induce neurite outgrowth (Fig.5).
 signaling and PI3K/Akt/GSP3pathway: Regulation of MT assembly and neurite
outgrowth.
The connection between the PI3K pathway and Ghas been demonstrated previously. PI3K-
was found to be a downstream effector of G-in neutrophil migration, inflammation and
chemotaxis (Stephens et al., 1997) and recent results suggest that the activation of PI3K/Akt
pathway by NGF is, in part, mediated through the subunit (Wu and Wong, 2005a and 2005b;
Wang and Wong, 2009). This correlates with previous studies from our laboratory that have
shown that G overexpression in PC12 cells was sufficient in the promotion of neurite formation
(Sierra-Fonseca et. al 2014) as well as in increasing levels of pAkt and pGsk3Jose Varela, MS
thesis UTEP 2016). These results suggest that Gco-ordinates with PI3K/AKT/GSK3 to
regulate neurite outgrowth and morphogenesis (Fig.5), and my research focuses to determine if
4-NP interferes with this pathway to disrupt MT assembly/neurite outgrowth, and induce
neurodegeneration.
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Fig. 5. G-MT mediated pathway and PI3K signaling coordinate to regulate MT assembly and
neurite outgrowth. NGF is known to acts through TrkA receptors to activate PI3K/AKT/GSK3β to
induce neurite outgrowth (left panel). The results from our laboratory demonstrate that NGF utilizes G,
a key component of the GPCR pathway (right panel), to alter MT assembly by means of its, interaction
with MTs, ultimately leading to neurite outgrowth and differentiation (central panel).

13

Hypothesis and specific aims.
The goal of the proposed study is to examine how 4-Nonylphenol (4-NP), a prevalent
endocrine-disrupting compound (EDC) causes neurodegeneration. Although 4-NP has been
shown to affect brain development and cause neurodegeneration, the mechanism by which 4-NP
exerts its effect in neurons is not understood. Recent results from our laboratory indicate that 4NP inhibits nerve growth factor (NGF)-induced neuronal differentiation of PC12 cells and causes
disruption of microtubule (an important component of the neuronal cytoskeleton). The
expression of the tau protein was increased significantly in the presence of 4-NP. Tau is a
microtubule-associated protein found in axons and it is known to regulate MT assembly and
neurite outgrowth. High-Resolution proteomic analysis of a cytoskeletal fraction (CSKF) reveals
that 4-NP altered the proteomic landscape of CSK and increased the association of several
proteins, including proteins of Alzheimer’s (AD) and Parkinson’s Disease (PD) pathways, with
the cytoskeleton (CSK). 4-NP has been shown to inhibit tubulin-G interactions. G is an
important component of the GPCR (G protein-coupled receptor) signaling pathway and its
interaction with tubulin/MTs has been shown to be important for MT assembly and neurite
outgrowth. Based on these results, in the current investigation, I hypothesize that 4-NP induces
neurodegeneration by disrupting cytoskeleton and altering expression/localization of Tau protein.
I further hypothesize that G and downstream PI3K/pAkt/pGSK3b signaling pathways is
involved in this process. PC12 cells and human neuroblastoma SHSY5Y cells are used for this
study. We propose to test our hypotheses by addressing the following two Specific Aims.
Specific Aim-1: Elucidate the cytoskeletal changes that occur in response to 4-NP
leading to neurodegeneration
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Specific Aim-2: Determine if 4-NP interferes with G/PI3K dependent signaling
pathway to promote cytoskeletal disruption and neurodegeneration.
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Chapter 2: Materials and Methods
2.1 Cell culture, NGF, and 4-NP treatment.
PC12 cells were grown in Dulbecco’s modified Eagle’s Medium (DMEM) (4.5 g/L
glucose, L-glutamine, without pyruvate), supplemented with 10% bovine calf serum (BCS), and
penicillin (100U/mL)-streptomycin (100um/mL) at 37ᵒC in 5% CO2 in 75 cm2 culture flasks. For
NGF treatment, PC12 cells were grown in 100 mm plates to 75% confluence over 1-2 days, then
treated with 100ng/mL of nerve growth factor (NGF) (Sigma-Aldrich, St. Louis, MO) dissolved
in complete media for 2-3 consecutive days. Control cells were grown in the same conditions
without NGF. For 4-NP treatment, a 5M or 10M solution of 4-NP dissolved in complete
media was added to the cells overnight. A stock solution of 10mM 4-NP was prepared by
dissolving the compound in DMSO to perform the treatments.
SHSY5Y cells were grown in Dulbecco’s modified medium/Ham’s F-12 50/50 mix
(DMEM/F-12 50/50) supplemented with 10% fetal bovine serum (FBS), and penicillin
(100U/mL)-streptomycin (100um/mL) at 37ᵒC in 5% CO2 in 75 cm2 culture flasks. For 4-NP
treatment, SHSY5Y the method described above for PC12 cells was followed. A stock solution
of 10mM 4-NP was prepared by dissolving the compound in DMSO to perform the treatments.
2.2 Preparation of whole-cell lysate.
After treatments with NGF, and/or 4-NP, culture media was removed and the cells were
washed with PBS and lysed by incubation in 500uL of lysis buffer (10mM Tris-HCl, pH 7.9,
1.5mM MgCl2, 0.3M sucrose, 0.1% Triton X-100, 1mM DTT, 10 uM GTP) supplemented with
protease and phosphatase inhibitor cocktail for 10 min over ice. Cells where then scraped and
sonicated for 1 min. (3 sonications of 20 seconds each, on ice to prevent heating of samples),
followed by centrifugation at 12,000 rpm for 10 min. at room temperature. Proteins
16

concentrations were determinate by the Bradford assay and all samples were leveled to obtain the
same protein concentration in all the experimental vials. Loading dye was added as required for
the immunoblotting protocol.
2.3 Electrophoresis and immunoblotting.
Samples for immunoblotting were run through a sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE) followed by electrotransfer onto a nitrocellulose membrane
(Leammil 1970; Towbin et al., 1970) which were then incubated for 1 hour at room temperature
in blocking solution (5% dry milk in 10%Tris-Sulfate Buffer). Subsequently, the membranes
were incubated overnight at 4ᵒC in with mouse monoclonal anti-alpha-tubulin (DMIA, Sigma
Aldrich, 1:100), Rabbit polyclonal anti G (Santa Cruz Biotechnology, 1:100), antibodies in
TBS. Membranes were washed three times with 0.05% Tween-20 in TBS (TBST) and incubated
with the appropriate HRP-conjugated secondary antibodies (goat anti-mouse or goat anti-rabbit
from Promega, Madison WI; 1:1000) in TBST for one hour. Chemiluminescence (ECL)
technique (SuperSignal West Pico Chemiluminescence Substrate) was used according to the
manufacturer’s instructions (Pierce Biotechnology, Rockford, IL). Quantitative analysis of the
protein bands was performed with the ThermoFisher, iBright image acquisition and analysis
software.
2.4 Co-immunoprecipitation.
Whole-cell lysate from SHSY5Y cells sample was incubated in anti-alpha-Tubulinprotein specific antibody (mouse monoclonal anti-alpha-Tubulin, DMIA (or mouse monoclonal
antibody derives from hybridoma in Dr. Francia’s laboratory at UTEP) overnight at 4ᵒC. 100uL
of 50% protein A-sepharose (Amersham Biochemical, Piscataway, NJ), pre-equilibrated in
10mM Tris-HCl, pH 8.0 was added to the samples to allow for a 2 hours incubation. Samples
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were then centrifuged at 12,000rpm for 8 min, and the pellet was washed with wash buffer
(25mM Tris-HCl, pH 7.2, 150mM NaCl). The pellets were washed 6 times in total, followed by
immunoblotting sample preparation.
2.5 Immunofluorescence and confocal microscopy.
Cells were allowed to attach to glass coverslips placed in 12-wells plates and were then
treated as described above. Media was then removed, cells were fixed by methanol fixation
method [Montoya et al., 2007], then washed three times with PBS, blocked for 1 hour at room
temperature in 500 L of 5% normal goat serum (NGS) (Sigma-Aldrich) in PBS. Primary
antibody incubation was performed for 1 hour at room temperature in the dark (anti-alphatubulin-Alexa Fluor 488-conjugated, and anti-G-Alexa Fluor 647-conjugated). In 1% NGS in
PBS. Coverslips were then mounted into slides using a drop (~15uL) of ProLong Gold anti-fade
reagent with DAPI. High-resolution, digital, fluorescent images were captured by using an
inverted, confocal laser-scanning microscopy (LSM 700; Zeiss, Thornwood, NY) employing a
Plan-Apochromat 40x/1.4 and 60x/1.6 immersion oil DIC objectives and assisted with 2009 ZEN
software (Zeiss, Thornwood, NY). DAPI (blue), Alexa Fluor 488 (green), and Alexa Fluor 647
(red) were excited with laser emissions of 405-, 488-, and 555-nm wavelengths, respectively.
2.6 Polymerization Assay.
In vitro, MT polymerization assay was performed using the Tubulin Polymerization
Assay Kit by Cytoskeleton Inc. The kit provides neuronal tubulin subunits attached to a
fluorescent reporter. Tubulin samples were prepared according to the kit manual provided to
obtain the tubulin control samples, positive control samples (using Taxol as a polymerization
enhancer), negative control samples (containing Nocodazol as polymerization inhibitor), and 4NP samples to assess the effects of the toxin in tubulin polymerization. Besides the treatment
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mentioned above, all samples contained PEM buffer along with GTP to allow for normal
polymerization conditions. After the samples were placed in a 96 wells plate, they were analyzed
using a fluorimeter for a 1 hour period.
2.7 Cytotoxicity Assay.
To determine the levels of cytotoxicity caused by the 4-NP, a previously described DNS
assay adapted for high-throughput screening was used (Lerma et. al., 2011). This assay uses two
fluorescent nucleic acid intercalators, Hoechst 33342 (Hoechst) and propidium iodide (PI).
Briefly, PC12 cells were seeded in a 96-well plate format and incubated with 4-NP at different
concentrations overnight (1uM, 5uM, 10uM, 12uM, 15uM, 18uM, 20uM, and 25uM), as well as
H2O2 (positive controls). Two hours before image capturing, cells were added with a staining
mixture of Hoechst and PI at a final concentration of 1 µg/mL for each dye. Subsequently, cells
were imaged in live-cell mode using a BD Pathway 855 Bioimager system (BD Biosciences,
Rockville, MD). Montages (2x2) from four adjacent image fields were captured per well in order
to acquire an adequate number of cells for statistical analysis, utilizing a 10x objective. To
determine the percentage of dead cells from each individual well, both image acquisition and
data analysis were performed using the BD AttoVision v1.6.2 software (BD Biosciences), and
each experimental condition was assessed with 8 replicates.
2.8 Statistical analysis.
All statistical analyses were performed using Sigma Plot 11 software (Systat Software,
Chicago, IL, USA). In the case of Western blot quantitative analysis, the differences between
controls and treatments were assessed by means of the Student’s paired t-test. For comparisons
between two groups, the Student’s paired t-test was employed, and in all cases, a value of p <
0.05 was considered to be statistically significant.
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Chapter 3: Results
3.1 Specific aim 1: Establish the cytoskeletal changes that occur in response to 4-NP leading
to neurodegeneration.
3.1.1Objective and overview
During the process of neurodegeneration, MT assembly and proteins associated with MTs
are severely altered. Under normal conditions, microtubule-associated protein Tau binds to MTs,
stabilizing neuron structure and integrity. In Alzheimer’s disease (AD), tau is hyperphosphorylated and does not bind to the MTs. Lewy bodies, which are considered
cytopathological markers of Parkinson’s disease (PD), are comprised of tubulins, MAP1, and
MAP2 (17-19). Our preliminary results indicate that the integrity of the MT network is severely
altered by 4-NP treatment in PC12 cells. In addition, Tau protein expression was increased in
the presence of 4-NP. Proteomic analysis revealed that the association of several proteins of
AD/PD pathways with the CSK fraction was increased after 4-NP treatment. Therefore, in Aim1, cytoskeletal alterations in the presence of 4-NP were investigated using neuronal cells
SHSY5Y. In addition, PC12 cells were also used to accomplish this aim. Following two subaims were addressed.

(1) Establish 4-NP-induced disruption of neurite outgrowth and MT assembly/organization.
(2) Does 4-NP alter the expression/localization of Tau proteins?
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3.1.2 Results
3.1.2.1 4-NP inhibits neurite formation and disrupts MT organization in PC12 cells
To determine the effects of 4-NP in MT organization, and neurite formation in NGF
differentiated PC12 cells, PC12 cells treated with 100 ng/mL NGF over the curse of two days to
allow for neuronal differentiation followed by 4-NP (1 µM and 5 µM) treatment overnight, as
indicated in the figure (Fig. 6). Cells were fixed by methanol and label with monoclonal antitubulin (red) primary antibody and processed for confocal microscopy. In control cells, tubulin is
localized evenly throughout the cell body. After NGF treatment, most of the cells showed neurite
formation and tubulin can be seen localized along the neurites of the cells as well as in the cell
bodies. In the presence of 4-NP, neurite formation is inhibited (1 and 5 µM treatments). As the
concentration of 4-NP increases, cell aggregation, and neurite loss were more persistent. A
quantitative assessment of neurite measurement indicated that the percentage of cells bearing
neurites was inhibited by 4-NP in a dose-dependent manner (Fig. 6 B). A cell was considered
neurite-bearing if it contained at least one neuronal process that was longer than the cell body
(~14mm in diameter). However, the average neurite length of the surviving neurites was
increased by 5mM 4-NP treatment (Fig. 6 C). This outcome was expected because we found that
only a few longer neurites survived in the presence of 4-NP. Shorter neurites (developing
neurites) were not found after 4-NP treatment. These results clearly suggest that 4-NP disrupts
MTs, inhibits neurite formation and promotes cellular aggregation in NGF-differentiated PC12
cells.
Using cytotoxicity assay it was determined earlier that the viability of NGF differentiated
PC12 cells was not altered after treatment with 4-NP (Jessica Martinez) indicating that 4-NP
effect on neuronal differentiation is not due to cells death and could be due MT disruption.
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Fig. 6. Effect of 4-NP on (A) MT organization and cellular morphology in PC12
cells; (B) Quantitative assessment neurite formation; (C) average neurite length. PC12 cells
were allowed to differentiate in the presence of NGF followed by treatment with 4-NP overnight.
Samples were processed for confocal microscopy using anti-DAPI (blue), and anti-tubulin (red).
In NGF treated cells, neurite outgrowth was observed. After 4-NP treatment, most of the cells
had lost their neurites, and aggregation of cells was observed. Increases in the treatment
concentration showed a more dramatic change in morphology and increased aggregation.
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3.1.2.2 4-NP inhibits neurite formation and disrupts MTs in SHSY5Y cells.
Although PC12 cells are used as model cell lines to study neuronal differentiation, they are
derived from the adrenal glands and are not of neuronal origin. Therefore, we tested the effect of 4-NP
(10 M) on neuronal cells SHSY5Y (human-derived). To determine the effects of 4-NP in MT

organization, and neurite formation in SHSY5Y cells, the cells were seeded in 12-well plates
with glass coverslips overnight to allow for cell attachment, followed by 4-NP (10 µM) treatment
overnight, as indicated in the figure (Fig. 7). Cells were fixed by methanol protocol and label
with monoclonal anti-tubulin (red) primary antibody and processed for confocal microscopy. In
control cells incubated in the absence of 4-NP, tubulin is localized evenly throughout the cell
body of the cell. In these cells, tubulin can be seen localized also along the neurites and
processes they exhibit. In 4-NP presence, neurite formation is inhibited, aggregation of cells was
also observed. These results clearly suggest that 4-NP disrupts MTs, inhibits neurite formation
and disrupts the MT organization in SHSY5Y cells.
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Fig. 7. 4-NP effect on tubulin expression in SHSY5Y cells. SHSY5Y cells were
allowed to attach to glass coverslips followed by treatment with 4-NP overnight. Samples were
processed for confocal microscopy using anti-DAPI (blue), and anti-tubulin (red). In control
SHSY5Y cells, neurite formation is observed and tubulin is expressed along the neurites and cell
body. In 4-NP treated cells, neurite formation is loss and an increase in the cell body is observed.
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3.2.1. 3. 4-NP does not have a significant effect in SHSY5Y cells viability.
To determine if 4-NP induced neuronal cell death at the concentration used in this study
(10M), a Cytotoxicity assay was performed using the Dual Nuclear Staining DNS) assay as
described in the method. SHSY5Y cells were treated with different concentrations of 4NP
overnight. Cells were prepared for cytotoxicity analysis using Hoechst and PI at a final
concentration of 1g/mL Samples were then analyzed using IN Cell Analysis 1000. Hydrogen
peroxide were used as positive controls. 4-NP at 10uM shows the same level of cell death (10%)
as control cells (in the absence of 4-NP) (Fig. 7). These results suggest that 4-NP at 10M
concentration is not toxic to cause cell death. Therefore, the results observed on the SHSY5Y
cells by the exposure of 4-NP are not due to cell death.
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Fig. 8. Effect of 4-NP on SHSY5Y cells viability. SHSY5Y cells were treated with
different concentrations of 4NP overnight (1uM, 5uM, 10uM, 12uM, 15uM, 18uM, 20uM, and
25uM), as well as DMSO and H2O2 at 1uM (positive and negative controls). Cells were
prepared for cytotoxicity analysis using Hoechst and PI at 1mg/mL Samples were then analyzed
using IN Cell Analysis 1000. 4-NP at 10uM shows the same level of cell death (10%) than cells
under normal conditions and cells under DMSO treatment. Cell death percentage starts to
increase at 4-NP 20uM concentration.
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Proteomic analysis of cytoskeleton
Proteomic analysis reveals that 4-NP alters the profile of cytoskeletal proteins, and G
protein subunits in NGF-differentiated cells (Carreon 2017). Many proteins in AD, PD, and HD
pathways were significantly up-/down-regulated in CSK after treatment with 4-NP. Reviewing
the proteomic results we identified the following potential targets by 4-NP for inducing
neurodegeneration (Table-I). Future studies will involve understanding the role of these proteins
in 4-NP-induced neurodegeneration.
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3.1.2.3 4-NP increases Tau protein expression and decreases the interaction between Tau
and Tubulin protein in SHSY5Y cells.
To determine if 4-NP affects tau expression and its interaction with MTs in SHSY5Y
cells, cells were seeded in 100mm plates, followed by treatment with 4-NP as indicated in the
figure (Fig. 9 a, b). Whole-cell lysates (WCL) were prepared as indicated in the methods to
determine if tau expression is altered in the presence of 4-NP. The co-immunoprecipitation (COIP) analysis was used to determine the interactions between tubulin and tau as described in the
method.

Briefly, the monoclonal anti-tubulin antibody was used for immunoprecipitation.

Immunocomplex was then subjected to western blotting using anti-tau antibody (Fig. 9 a, b).
This experiment was repeated two times with duplicates and statistical analysis was carried out
using one-way ANOVA. Controls represent 100%. Tau expression was increased after 4-NP.
The differences in the mean values among the treatment groups are greater than would be
expected by chance; there is a statistically significant difference (P = 0.031). Tau interaction with
tubulin was decreased after 4-NP exposure. The differences in the mean values among the
sample groups are greater than would be expected by chance; there is a statistically significant
difference (P=0.044).
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b)

a)

Fig. 9 Tau protein expression is increased and its interaction with MT decreased in
SHSY5Y after 4-NP treatment. Effect of 4-NP on the expression of Tau and the interaction
between Tau and Tubulin protein in SHSY5Y cells. SHSY5Y cells were plated in 100 mm.
Subsequently, cells were treated with or without 4-NP overnight. Whole-cell lysates and Co-IP
samples were prepared as described in the methods. Equal amounts of proteins from each sample
were subjected to immunoblot analysis using the anti-Tau antibody as indicated. Protein bands
were detected using the ECL-plus reagent, quantitated, and expressed as indicated in the figure.
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3.1.2.4 4-NP disrupts MT and Tau organization on SHSY5Y cells.
To determine the effects of 4-NP in MT and Tau organization, as well as neurite
formation in SHSY5Y cells, SHSY5Y cells were seeded in 12-well plates with glass coverslips
overnight to allow for cell attachment, followed by 4-NP (10 µM) treatment overnight, as
indicated in the figure (Fig. 10). Cells were then fixed by methanol protocol and labeled with
monoclonal anti-tubulin (green), and anti-tau (red) primary antibodies, and processed for
confocal microscopy. In control cells, tubulin and tau are colocalized throughout the cell body
and the neurites of the cell. After 4-NP treatment, neurite formation is inhibited, aggregation of
cells is observed and the colocalization and general organization of the MT and tau proteins are
altered. Both tubulin and tau proteins are being localized mainly in the cell membrane, instead of
thought the cell. These results clearly suggest that 4-NP disrupts MTs and tau organization,
inhibits neurite formation and disrupts the MT organization in SHSY5Y cells.
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Fig. 10. 4-NP disrupts MT and Tau organization in SHSY5Y cells. Effect of 4-NP on
the organization of Tubulin and Tau in SHSY5Y cells. Samples were processed for confocal
microscopy using anti-DAPI (blue), anti-tubulin (green), and anti-tau (red). Colocalization
between Tau and tubulin was observed mainly in the neuronal processes in the untreated cells. In
4-NP treated cells suffered a change in morphology, a loss of neurites is observed, and even
when colocalization of Tubulin and Tau is still observed, it is more prevalent on the cell
membrane of the cells.
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3.1.2.5 4-NP does not have a significant direct effect in tubulin polymerization in
vitro.
To determine if the effects of 4-NP in MTs was caused directly by 4-NP, an in vitro MT
polymerization assay was performed using the Tubulin Polymerization Assay Kit by
Cytoskeleton Inc. Tubulin molecules were mixed along with PEMP buffer, and 4NP. For this
experiment nocodazole was used as a negative control, and Taxol was used as a positive control.
The results were observed using a fluorometer. Even when some inhibition of MT assembly can
be observed in the graph, it is not significant compared with the control sample (Fig. 11). The
result indicates that 4-NP does not have any direct effect on MT assembly in vitro. Therefore,
the effects of 4-NP in MT disruption as observed in PC12 and SHSY5Y cells, are more likely to
be mediated by tau, G and downstream signaling pathways as described in this study.
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Fig. 11. Polymerization of MT in vitro is not significantly altered by 4-NP exposure.
A representative graph of the effect of 4-NP on the assembly of tubulin subunits in vitro. Using
the Tubulin Polymerization Assay Kit by Cytoskeleton Inc. the samples were treated with taxol,
(orange) nocodazole, (gray) buffer (light blue) or 4-NP at 5uM (yellow) or 10uM (dark blue).
Samples treated with 4-NP show a partial assembly inhibition of tubulin compared with the
control samples.
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3.2 Specific aim 2: Determine if 4-NP interferes with G/PI3K dependent signaling
pathway to promote cytoskeletal disruption and neurodegeneration.
3.2.1 Objectives and Overview:
The goal of this aim is to determine the signaling pathway by which 4-NP interferes with
MT assembly and neurite outgrowth and induces neurodegeneration. Recently, it was found that
the interaction of G with MTs is important for nerve growth factor (NGF)-induced neuronal
differentiation of PC12 cells and that the blocking of the interaction between G and
tubulin/MT disrupted MTs, inhibited neurite outgrowth and induced axonal damage indicating
the involvement of G in these processes. NGF-induced neuronal differentiation of PC12 cells
also activates receptor tyrosine kinase (TrkA) and its downstream effector Phosphatidyl inositol3-kinase (PI3K). Activation of PI3K promotes the phosphorylation of downstream AKT and
GSK-3β, which subsequently participate in the regulation of neurite outgrowth, and are
particularly associated with microtubule remodeling. Overexpression of G in PC12 cells has
been shown to induce neurite outgrowth (Sierra-Fonseca et al.,2014 ) and phosphorylate Akt and
GSK3 supporting the notion that G and PI3K pathway co-ordinate to regulate MT assembly
and neurite outgrowth.

4-NP has been shown to inhibit tubulin-G interactions, disrupts

MTs/G organization in NGF-differentiated PC12 cells (MS thesis, Cynthia Carreon). The goal
of the aim-2 is to determine if 4-NP inhibits G-MT interactions in SHSY5Y cells, and
interferes with the PI3K pathway both in PC12 and SHSY5Y cells. PI3K signaling pathway in
both PC12 and SHSY5Y cells (erase) Both PC12 cells and neuronal cells SHSY5Y were used
to accomplish this aim using the following sub-aims.
(1) Determine whether 4-NP inhibits the interaction of G and tubulin/MT interaction
in SHSY5Y cells.
(2) Determine if 4-NP interferes with the phosphorylation of Akt and GSK3 in SHSY5Y
cells.
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3.2.2 Results.
3.2.2.1 4-NP disrupts tubulin/MT and G organization on SHSY5Y cells.
To analyze the effect 4-NP has on the organization and localization of G in SHSY5Y
cells, SHSY5Y cells subjected to 4-NP (10uL) treatment overnight were subjected to confocal
microscopy as described above. Methanol fixation protocol was employed. Cells were incubated
in Alexa Fluor 546 conjugated-G primary antibody, and Alexa Fluor 488 conjugated-tubulin
primary antibody. After mounting the slides with mounting media with DAPI. In control cells
incubated in the absence of 4-NP, tubulin and G are colocalized throughout the cell body and
the neurites of the cell. After 4-NP treatment, neurite formation of cells is inhibited, and the
colocalization and general organization of the MT and G/tubulin proteins are altered. Both
tubulin and G proteins are being localized mainly in the cell membrane, instead of thought the
cell (Fig. 12). These results clearly suggest that 4-NP might inhibit the interaction of G and
tubulin/MT organization, inhibits neurite formation and disrupts the general MT organization in
SHSY5Y cells.
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Fig. 12. Disruption of tubulin/MT and G organization on SHSY5Y cells after 4NP treatment. Effect of 4-NP on the organization of Tubulin/MT, and G in SHSY5Y cells.
Samples were processed for confocal microscopy using anti-DAPI (blue), anti-tubulin (green),
and anti-G (red). Colocalization between G and tubulin was observed mainly in the neuronal
processes in the control (untreated) cells. In 4-NP treated cells suffered a change in morphology,
a loss of neurites is observed, and even when colocalization of Tubulin and G is still observed,
it is more prevalent on the cell membrane of the cells.
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3.2.2.2 4-NP increases G expression and decreases its interaction with MT in
SHSY5Y cells.
To determine if 4-NP affects the interaction of G with tubulin and its expression levels
in SHSY5Y, SHSY5Y cells were plated in 100 mm plates, following the methodology
previously described, followed by overnight treatment of 4-NP at a concentration of 10M as
indicated in the figure (Fig. 13). Whole-cell lysate (WCL) and co-immunoprecipitation (CO-IP)
samples were prepared as indicated in the methods. For CO-IP samples, the monoclonal antitubulin antibody was used. Samples were then processed for western blotting using anti-G. This
experiment was repeated two times with duplicates and statistical analysis was carried out using
paired t-Test. Controls represent 100%. G expression was increased after 4-NP. G interaction
with tubulin protein was decreased after 4-NP exposure. However, the differences in the mean
values among the sample groups are not greater than would be expected by chance; there is not a
statistically significant difference. These results suggest that 4-NP might inhibit the interaction of
G and tubulin, even when the levels of G expressed by SHSY5Y cells is increased.

37

Fig. 13. G expression increased while its interaction with tubulin decreases after 4NP treatment. Effect of 4-NP on the expression of G and the interaction between G and
Tubulin protein in SHSY5Y cells. SHSY5Y cells were plated in 100 mm. Subsequently, cells
were treated with or without 4-NP overnight. Whole-cell lysates and Co-IP samples were
prepared for western blot as described in the methods. Equal amounts of proteins from each
sample were subjected to immunoblot analysis using an anti- G antibody as indicated. Protein
bands were detected using the ECL-plus reagent, quantitated, and expressed as indicated in the
figure.
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3.2.2.3 4-NP decreases pAkt expression in SHSY5Y cells.
To examine the effect of 4-NP on the phosphorylation of Akt molecules in SHSY5Y
cells, SHSY5Y cells were seeded in 100 cm2 plates. Afterward, the cells were treated or not
overnight with 4-NP at 10mM. Whole-cell lysates were then processed as indicated in the
methods and prepared for western blotting, followed by immunoblotting with the aid if anti-G
antibodies. Protein bands were detected using the ECL-plus reagent, quantitated, and expressed
as indicated in the figure. This experiment was repeated two times with duplicates and statistical
analysis was carried out using paired t-Test. Controls represent 100%. pAkt expression was
decreased after 4-NP (Fig.14). However, the differences in the mean values among the sample
groups are not greater than would be expected by chance; there is not a statistically significant
difference. These results suggest that 4-NP might inhibit the expression of pAkt, which could
suggest that it affects the PI3K pathway in SHSY5Y cells.
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Fig.14 pAkt expression decreases after 4-NP exposure in SHSY5Y. Effect of 4-NP on the
expression of pAkt in SHSY5Y cells. SHSY5Y cells were plated in 100 mm. Subsequently, cells
were treated with or without 4-NP at 10M overnight. Whole-cell lysates were prepared for
western blot as described in the methods. Equal amounts of proteins from each sample were
subjected to immunoblot analysis using an anti- G antibody as indicated. Protein bands were
detected using the ECL-plus reagent, quantitated, and expressed as indicated in the figure.
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3.2.2.4 4-NP decreases pGSK3 protein expression after 4-NP treatment in SHSY5Y
cells.
To determine the effect of 4-NP on the expression of phosphorylated GSK3 molecules
in SHSY5Y cells, SHSY5Y cells were seeded in 100 cm2 plates. Afterward, the cells were
treated or not overnight with 4-NP at 10mM. Whole-cell lysates were then processed as indicated
in the methods and prepared for western blotting, followed by immunoblotting with the aid if
anti-pGSK3 antibodies. Protein bands were detected using the ECL-plus reagent, quantitated,
and expressed as indicated in the figure. This experiment was repeated two times with duplicates
and statistical analysis was carried out using paired t-Test. Controls represent 100%. pGSK3
expression was decreased after 4-NP (Fig. 15). The differences in the mean values among the
sample groups are greater than would be expected by chance; there is a statistically significant
difference (P=0.046)

41

Fig. 15. pGSK3b expression decreases significantly after 4-NP treatment. SHSY5Y
cells were plated in 100 mm. Subsequently, cells were treated with or without 4-NP at 10M
overnight. Whole-cell lysates were prepared for western blot as described in the methods. Equal
amounts of proteins from each sample were subjected to immunoblot analysis using an anti- G
antibody as indicated. Protein bands were detected using the ECL-plus reagent, quantitated, and
expressed as indicated in the figure.
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Chapter 4: Discussion
Neurodegeneration is a pathological condition associated with a progressive loss of
neurons and occurs in many neurological disorders including Alzheimer’s disease (AD),
Parkinson’s disease (PD) and ALS. It is the most common cause of dementia among people 65
and older. Because of increasing life expectancy, the prevalence of neurodegenerative diseases is
increasing rapidly. Although the speed of research has also been increased significantly, clinical
trials have yielded mostly disappointing results, suggesting that focus on identifying new
strategies and target(s) for therapeutic interventions should be re-evaluated. Recent evidence
suggests that environmental chemicals that act as endocrine disruptors (EDC) may adversely
affect brain development and induce neurodegeneration. 4-NP is an endocrine disruptor that can
induce neural stem cell death and affect neurite outgrowth in Xenopus spinal cord neurons.
Since cytoskeletal defect and dysfunction is the hallmark of neurodegeneration, we proposed to
elucidate the cytoskeletal changes that occur in response to 4-NP and to investigate the signaling
pathway by which 4-NP alters the cytoskeleton and induces neurodegeneration.

It was found that 4-NP inhibited NGF-induced neuronal differentiation of PC12 cells and
disrupted MTs (Fig.6). Since PC12 cells are not of neuronal origin, neuronal cells SHSY5Y were
used to test the effect of 4-NP and found that 4-NP has a similar effect on SHSY5Y cells (Fig.7).
During the process of neurodegeneration, MT associated protein Tau is severely altered. Our
results indicate that tau expression increases significantly when exposed to 4-NP in SHSY5Y
cells and the interaction between tau and MT is significantly decreased (Fig. 9). These results are
similar to those obtained by confocal microscopy, where it can be appreciated that the
morphology of SHSY5Y cells, as well as the location/organization of the tau and tubulin
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proteins, is disrupted and changes dramatically after 4-NP exposure (Fig.7 and Fig.10). These
support the initial hypothesis that 4-NP induces neurodegeneration by disrupting the
expression/localization of Tau protein and its interaction with MTs.

Dynamic rearrangement of microtubules (MTs) is critical for growth-cone motility and
neurite outgrowth. Previously, Gβγ has been shown to play a key role in this process by
stimulating MT assembly required for neurite outgrowth. This was further supported by the fact
that blocking Gβγ-MT interaction by a Gβγ-sequestering peptide, GRK2i, inhibited neurite
outgrowth and induced neurodegeneration (Sierra Fonseca et. al., 2014). The observation that 4NP alters MT organization and its association with Gβγ suggests that 4-NP induces
neurodegeneration by affecting the Gβγ-MT mediated pathway. Our results indicate that after 4NP exposure, not only is G expression decrease, but also the expression of downstream
effectors of the G modulated pathway, PI3K, show a significant decrease, specifically
pGSK3These results support the proposed hypothesis that 4-NP dependent MT disruption and
neurodegeneration involves the interaction with G and the effectors of the PI3K pathway in
order to induce neurodegeneration.

In summary, I have demonstrated that 4-NP at a concentration of 10M was potent
enough to induce neurodegeneration by the PI3K/pAkt/pGSK3 pathway. Using the neuronal
SHSY5Y cell line as a model system, this study clearly demonstrates the potential risk of 4-NP
in inducing neurodegeneration and should provide essential information to assess the
environmental risk of 4-NP and regulate the production of it.
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